KAREN DUBOIS: Open Payments
NPI 1124571799 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 30 payments from 13 companies in 2025. Trend: 2023 $54 · 2024 $118 · 2025 $787
Food & beverage: $702Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $152 |
| E.R. Squibb & Sons, L.L.C. | 7 | $142 |
| Janssen Scientific Affairs, LLC | 2 | $95 |
| Janssen Biotech, Inc. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Merck Sharp & Dohme LLC | 2 | $63 |
| Caris MPI, Inc. | 1 | $52 |
| Tempus AI, Inc | 1 | $33 |
| Astellas Pharma US Inc | 2 | $29 |
| PFIZER INC. | 1 | $27 |
Products named: OPDIVO, LYNPARZA, DARZALEX, KEYTRUDA, MI CANCER SEEK, LUTATHERA, XT CDX, Vyloy.
Industry payments across WA — which companies pay providers there.
